Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Frank J. Lagerwaard

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8740-2517; OpenAlex author ID A5036402068. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 3 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 10

  1. Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE t… Co-author DOI 10.1136/jitc-2024-010222↗
  2. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE… Co-author DOI 10.1016/s2468-1253(24)00017-7↗
  3. Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PAN… Co-author DOI 10.1186/s12885-023-10521-1↗
  4. Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single c… First author DOI 10.3389/fonc.2023.1149961↗
  5. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a na… Co-author DOI 10.1186/s12885-022-10419-4↗
  6. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Co-author DOI 10.1002/cam4.2100↗
  7. The role of biological dose-escalation for pancreatic cancer. First author DOI 10.1016/j.ctro.2019.04.020↗
  8. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy. Last author DOI 10.1016/j.radonc.2018.11.019↗
  9. SBRT for pancreatic cancer: In regard of Bohoudi et al. Co-author DOI 10.1016/j.radonc.2018.04.024↗
  10. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. Co-author DOI 10.1016/j.radonc.2017.07.028↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna M E Bruynzeel · 10 shared papers, 2017–2025 · strength 1.36
  2. Martijn Ruben Meijerink · 6 shared papers, 2019–2025 · strength 0.91
  3. Deesje Doppenberg · 3 shared papers, 2022–2023 · strength 0.43
  4. Johanna W. Wilmink · 3 shared papers, 2022–2023 · strength 0.43
  5. Geertjan van Tienhoven · 3 shared papers, 2022–2023 · strength 0.43
  6. Eva Versteijne · 3 shared papers, 2022–2023 · strength 0.43
  7. Marc G. Besselink · 3 shared papers, 2022–2023 · strength 0.43
  8. Geert Kazemier M · 3 shared papers, 2022–2023 · strength 0.43
  9. Hester J. Scheffer · 2 shared papers, 2024–2025 · strength 0.37
  10. Florentine E. F. Timmer · 2 shared papers, 2024–2025 · strength 0.37
  11. Alette H. Ruarus · 2 shared papers, 2024–2025 · strength 0.37
  12. Laurien G. P. H. Vroomen · 2 shared papers, 2024–2025 · strength 0.37
  13. Bart Geboers · 2 shared papers, 2024–2025 · strength 0.37
  14. Tanja D. de Gruijl · 2 shared papers, 2024–2025 · strength 0.37
  15. Miguel A. Palacios · 3 shared papers, 2017–2019 · strength 0.27
  16. Omar Bohoudi · 3 shared papers, 2017–2019 · strength 0.27
  17. Izaak Quintus Molenaar · 2 shared papers, 2022–2023 · strength 0.27
  18. Martijn Intven · 2 shared papers, 2022–2023 · strength 0.27
  19. Hanneke W.M. van Laarhoven · 2 shared papers, 2022–2023 · strength 0.27
  20. Bas Groot Koerkamp · 2 shared papers, 2022–2023 · strength 0.27
  21. Joost J.M.E. Nuyttens · 2 shared papers, 2022–2023 · strength 0.27
  22. Hjalmar C. van Santvoort · 2 shared papers, 2022–2023 · strength 0.27
  23. Casper H.J. van Eijck · 2 shared papers, 2022–2023 · strength 0.27
  24. Susan van Dieren · 1 shared paper, 2023 · strength 0.17
  25. Michael Frederick Bassetti · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.